Table 3. Other prevalent comorbidities in PLHIV and non-HIV matched controls.
| Total population | |||
|---|---|---|---|
| n (%) | PLHIV (n = 1,091) | Controls* (n = 2,181) | p-value** |
| Psychiatric disorders | |||
| Mental and behavioural disorders due to psychoactive substance use (ICD-10 code F10-19) | 123 (11.3) | 120 (5.5) | <0.001 |
| Depressive disorder (ICD-10 code F32-33) | 74 (6.8) | 47 (2.2) | <0.001 |
| Neurotic, stress-related and somatoform disorders (ICD-10 code F40-48) | 31 (2.8) | 26 (1.2) | 0.001 |
| Anaemia (ICD-10 code D50-64) | 81 (7.4) | 60 (2.8) | <0.001 |
| Malnutrition (ICD-10 code E40-46) | 56 (5.1) | 35 (1.6) | <0.001 |
| Nutritional deficiencies (ICD-10 code E50-64) | 36 (3.3) | 24 (1.1) | <0.001 |
| Malignant neoplasms (ICD-10 code C00-97) | 85 (7.8) | 120 (5.5) | 0.010 |
| Bone and articular cartilage | 0 (0.0) | 1 (0.0) | 1.000 |
| Breast | 7 (0.6) | 8 (0.4) | 0.273 |
| Connective and soft tissue | 9 (0.8) | 4 (0.2) | 0.014 |
| Digestive organs | 25 (2.3) | 20 (0.9) | 0.002 |
| Endocrine glands and related structures | 2 (0.2) | 9 (0.4) | 0.355 |
| Eye, brain and central nervous system | 1 (0.1) | 3 (0.1) | 1.000 |
| Lip, oral cavity and pharynx | 3 (0.3) | 15 (0.7) | 0.132 |
| Male genital organs | 9 (0.8) | 27 (1.2) | 0.286 |
| ther female genital organs | 4 (0.4) | 5 (0.2) | 0.492 |
| Respiratory system and intrathoracic organs | 4 (0.4) | 22 (1.0) | 0.051 |
| Secondary and ill-defined | 16 (1.5) | 19 (0.9) | 0.119 |
| Skin | 7 (0.6) | 17 (0.8) | 0.663 |
| Stated or presumed to be primary, of lymphoid, haematopoietic and related tissue | 20 (1.8) | 9 (0.4) | <0.001 |
| Urinary organs | 5 (0.5) | 4 (0.2) | 0.171 |
* non-HIV matched controls
**unadjusted in the matched sample
ICD-10: international classification of diseases 10th revision, PLHIV: patients living with human immunodeficient virus